A detailed history of Squarepoint Ops LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 28,808 shares of SRPT stock, worth $3.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,808
Previous 16,422 75.42%
Holding current value
$3.43 Million
Previous $2.59 Million 38.7%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $1.54 Million - $1.94 Million
12,386 Added 75.42%
28,808 $3.6 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $1.47 Million - $2.12 Million
12,946 Added 372.44%
16,422 $2.59 Million
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $325,701 - $491,958
3,476 New
3,476 $450,000
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $1.47 Million - $2.17 Million
-13,779 Reduced 13.7%
86,811 $9.94 Million
Q1 2023

May 15, 2023

SELL
$117.53 - $155.99 $12.4 Million - $16.5 Million
-105,906 Reduced 51.29%
100,590 $13.9 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $6.49 Million - $8.51 Million
64,394 Added 45.32%
206,496 $26.8 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $1.78 Million - $2.81 Million
23,527 Added 19.84%
142,102 $15.7 Million
Q2 2022

Aug 15, 2022

BUY
$62.69 - $88.44 $994,639 - $1.4 Million
15,866 Added 15.45%
118,575 $8.89 Million
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $4.41 Million - $6.32 Million
69,880 Added 212.86%
102,709 $8.02 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $2.54 Million - $3.26 Million
32,829 New
32,829 $2.96 Million
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $4.25 Million - $5.31 Million
-61,187 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $4.29 Million - $10 Million
59,372 Added 3271.18%
61,187 $4.56 Million
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $3.23 Million - $4.59 Million
-25,698 Reduced 93.4%
1,815 $309,000
Q3 2020

Nov 16, 2020

SELL
$127.12 - $172.34 $3.96 Million - $5.37 Million
-31,153 Reduced 53.1%
27,513 $3.86 Million
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $4.52 Million - $8.34 Million
48,566 Added 480.85%
58,666 $9.41 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $1.23 Million - $1.96 Million
-14,904 Reduced 59.61%
10,100 $988,000
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $1.91 Million - $3.39 Million
25,004 New
25,004 $3.23 Million
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $1.02 Million - $2.21 Million
-14,067 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $1.34 Million - $1.81 Million
-11,915 Reduced 45.86%
14,067 $2.14 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $2.77 Million - $3.94 Million
25,982 New
25,982 $3.1 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $4.16 Million - $5.82 Million
-36,055 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $738,563 - $1.58 Million
10,295 Added 39.97%
36,055 $4.77 Million
Q1 2018

May 15, 2018

BUY
$54.02 - $82.27 $246,439 - $375,315
4,562 Added 21.52%
25,760 $1.91 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $588,258 - $700,749
-12,348 Reduced 36.81%
21,198 $1.18 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $1.2 Million - $1.58 Million
33,546
33,546 $1.52 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.